Kelly on a heated day at the FDA and why a new drug class could bring diabetes patients, doctors, and educators closer to personalized therapy.

Frequent and careful blood glucose monitoring is unquestionably useful for people who take insulin, but is monitoring necessary for all patients

What’s an SGLT-2 inhibitor and how does it work? Includes cool FAQ!

In June 2012, Medtronic held an Investor Conference to describe its upcoming products and expectations for the next five years. One of the biggest news items for...

Wireless, cell phone-enabled, and data-to-the-cloud glucose meters are a new trend in diabetes, evidenced by the recent launch of Sanofi’s iBGStar (see test drive in...

How can the FDA change its view on drug approvals to give patients access to better therapies?

Our trip to Orlando brings smart, actionable advice on preventing high and low blood sugars from diabetes guru and educator Mr. Gary Scheiner.

Visiting your healthcare team? Kerri Sparling highlights the right questions to ask.

The World Health Organization (WHO) recently released its World Health Statistics 2o12 report, compiling data from 194 countries. The report estimates that about 9% of...

How can we make better use of our test strips?

On April 15, the FDA approved GlaxoSmithKline’s once-weekly GLP-1 agonist Tanzeum (albiglutide) for type 2 diabetes, which makes it the second once-weekly GLP-1 agonist...

On January 13, J&J LifeScan announced the launch of the OneTouch VerioSync blood glucose meter in the US. The meter sends blood glucose readings wirelessly (via...

MannKind’s inhalable ultra-rapid-acting insulin Afrezza has its day at the FDA – find out what it can do for patients and how to speak up!

In April, Asante Solutions started shipping its Snap insulin pump to users in the northeastern part of US. What’s unique about the Snap is that insulin cartridges are...

On March 4, Medtronic announced the creation of a new pilot program with Aetna to provide an insulin pump to up to 300 fully insured members with uncontrolled type 2...

The first quarter of 2013 has been eventful for Johnson & Johnson Diabetes Care. Animas Corporation submitted the Animas Vibe insulin pump to the FDA, integrated...

On February 19, Abbott announced a recall of FreeStyle and FreeStyle Flash blood glucose meters, which may produce low blood sugar results incorrectly when used with...

On April 17, Abbott announced a recall of the FreeStyle InsuLinx blood glucose meters due to software issues for readings of 1,024 mg/dl and above. The problem is...

LifeScan’s OneTouch VerioSync meter – the magic of wireless blood glucose data to your iPhone/iPod/iPad.

Five key insights from April’s big-deal artificial pancreas meeting in Washington, DC.